SINGER JAMES R 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-16 11:45 am Sale | 2023-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 3,000,000 3.700% | -2,000,000 (-40.00%) | Filing |
| 2023-02-14 10:40 am Purchase | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 5,000,000 8.100% | 2,535,000 (+102.84%) | Filing |
| 2022-01-24 08:22 am Purchase | 2022-01-13 | 13G | Verve Therapeutics, Inc. VERV | SINGER JAMES R | 2,465,000 5.100% | 2,465,000 (New Position) | Filing |